Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05096910` - Comparison Of Suture Materials on Sectio Scars (COSMOSS)	N/A
Withdrawn	`NCT02968459` - Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars	Phase 2
Completed	`NCT03676907` - Assessment of Single and Double Layer Suturation of Lower Segment Uterine Incision by USG After C/S	N/A
Completed	`NCT03629028` - Single or Double-layer Uterine Closure Techniques	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT05096910 - Comparison Of Suture Materials on Sectio Scars (COSMOSS)

N/A

Withdrawn

NCT02968459 - Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars

Phase 2

Completed

NCT03676907 - Assessment of Single and Double Layer Suturation of Lower Segment Uterine Incision by USG After C/S

N/A

Completed

NCT03629028 - Single or Double-layer Uterine Closure Techniques

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03181087
Study type	Interventional
Source	Maternal and Child Health Hospital of Foshan
Contact
Status	Withdrawn
Phase	Phase 1
Start date	December 11, 2021
Completion date	May 30, 2023

Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms